TheraSonic, a CEA spin-off created end of 2023, closes a fundraising led by the venture studio M2care for the development of a breakthrough technology designed to improve drug delivery into the brain
TheraSonic, a startup founded at the end of 2023 and emerging from CEA, announces a fundraising of €1 million to finance the development of its robotic medical device designed to improve drug delivery in the brain through the use of focused ultrasound.